The effect of a-amino-3-hydroxy-5-methylisoxazolepropionate (AMPA) on Ca2+-sensitive, tetrodotoxin (TTX)-insensitive K'-stimulated [3H]-L-glutamate release from rat hippocampal synaptosomes was determined. AMPA in the presence, but not in the absence of cyclothiazide, a drug which blocks AMPA receptor desensitization, elicited a dose-dependent increase in K'-stimulated [3H]-L-glutamate release but had no effect on basal release. The AMPA/cyclothiazide stimulation was blocked by CNQX and by GYKI 52466, an antagonist at the cyclothiazide site. These results indicate that AMPA receptors are present on presynaptic terminals and suggest that they may play a role in the regulation of neurotransmitter release.
Introduction lonotropic glutamate receptors can be subdivided into N-methyl-D-aspartate (NMDA) and non-NMDA (kainate and o-amino-3-hydroxy-5-methylisoxazolepropionate (AMPA)) subtypes and, to date, at least seven separate cDNAs encoding non-NMDA receptor subunits have been cloned and characterized. Among these GluRlGluR4 are proposed as the constituent subunits of functional AMPA receptors (Wenthold et al., 1992) .
AMPA receptors are important in a range of physiological (Barnes & Henley, 1992) and pathophysiological (Choi, 1992) processes including a long-term potentiation (LTP) in the rat hippocampus. LTP is of widespread interest since it has been proposed as an underlying molecular mechanism for learning and memory (Bliss & Collingridge, 1993) . Nonetheless, while the involvement of postsynaptic AMPA receptors in LTP has been demonstrated (Bliss & Collingridge, 1993 ) the existence of presynaptic AMPA receptors has not been established. Here we present evidence for funtionally relevant AMPA receptors on the presynaptic terminals in the rat hippocampus which regulate the release of neurotransmitter.
Methods The hippocampil were dissected from two female Wistar rats (100-170g) per experiment and synaptosomes were prepared as described previously (McMahon et al., 1989 Results The pharmacological integrity of the synaptomes was confirmed using the previously characterized ability of carbachol to inhibit endogenous and exogenously applied neurotransmitter release (Marchi et al., 1989 ) Consistent with those previous observations, in our assay system carbachol (100 pLM) reduced K+-stimulated release by 40% and that inhibition was completely inhibited by 0.1 tiM atropine (Figure 1) .
AMPA alone had no effect on stimulated release but in the presence of cyclothiazide AMPA potentiated K+-stimulated but not basal [3H]-L-glutamate release (Figure 2a hippocampal slices has also been observed recently but antagonism by GYKI 52466 was not reported (Desai et al., 1994) . The AMPA/cyclothiazide reponse was inhibited by CNQX and GYKI 52466. CNQX is a well characterized competitive antagonist at the AMPA binding site (Barnes & Henley, 1992) whereas GYKI 52466 is a highly selective noncompetitive antagonist of AMPA-evoked responses (Donevan & Rogawski, 1993) et al., 1993) in rat CNS. The mechanism of inhibition by GYKI 52466 has been proposed as promoting the rate of desensitization of AMPA receptors by interaction at the cyclothiazide site. Thus GYKI 52466 is believed to be a competitive antagonist at the same allosteric site at which cyclothiazide is an agonist (Zorumski et al., 1993) .
The results presented here are relevant to the debate over possible presynaptic mechanisms for the induction and maintenance of LTP. While the molecular mechanisms regulating neurotransmitter release in vivo remain to be determined, our data indicate that activation of presynaptic AMPA receptors, under conditions where desensitization is prevented, can increase release. Furthermore, we demonstrate that the recently available compounds cyclothiazide and GYKI 52466 and their subsequent derivatives will provide invaluable tools to study the properties of pre-and postsynaptic AMPA receptors.
